Opinion
Video
The Promise of Emerging IgAN Therapies
Author(s):
Key Takeaways
- Biomarkers, including genetic mutations and protein expressions, are vital for predicting disease progression and treatment response.
- Advanced diagnostic techniques are essential for identifying molecular and cellular indicators that inform patient prognosis.
Panelists discuss how emerging therapies are expected to address the unmet need for treatments that not only reduce proteinuria but also target the underlying immune dysfunction associated with IgA nephropathy.
- How do you believe emerging therapies will address the unmet need for treatments that reduce proteinuria while also modifying the disease’s underlying immune dysfunction?
- What are the most promising mechanisms of action being explored in these new therapies?
Related Videos
Related Content
